Lipid peroxide-lowering compositions

Details Lipid peroxide-lowering compositions Lipid peroxide-lowering compositions

2006-02-14

2006-02-14

Henley, III, Raymond J. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

C514S578000, C514S616000

Reexamination Certificate

active

06998422

ABSTRACT:
Compositions having excellent blood lipid peroxide lowering activity are provided. In particular, compositions for lowering lipid peroxides in the blood which contain pravastatin together with at least one substance selected from the group consisting of taurine, pantethine and inositol hexanicotinate. Use of these compositions enables the provision of excellent preventive or remedial agents capable of lowering the concentration of lipid peroxides in the blood which show effects of injuring vascular endothelial cells, accelerating platelet aggregation, forming foam cells, etc.

REFERENCES:
patent: 5662934 (1997-09-01), Najarian
patent: 6245797 (2001-06-01), Winokur
patent: 6544525 (2003-04-01), Yegorova
patent: 2003/0220343 (2003-11-01), Ohsawa et al.
patent: 2 077 264 (1981-12-01), None
patent: 55-76816 A (1980-06-01), None
patent: 58-69813 A (1983-04-01), None
patent: 60/41611 (1985-03-01), None
patent: 94/15592 (1994-07-01), None
patent: 97/38694 (1997-10-01), None
patent: 99/06035 X (1999-02-01), None
STN Registry File Abstract, Registry No. 6556-11-2 “Inositol, hexanicotinate, myo-”, copyright 2005 ACS on STN.
Biosis Abstract, Accession No. 1972:156777, Richard, A, Therapie der Gegenwart, (1971), vol. 110, No. 11, pp. 1679-1687.
Medline Abstract, Accession No. 81255317, Wechsler, et al., Artery (1980), 8(6), 519-29.
Hcaplus Abstract, Accession No. 122:129709, Deslypere, Journal of Internal Medicine, Supplement (1994), 236(736), 69-74.
Medline Abstract, Accession No. 8937733, Mitani et al., British Journal of Pharmacology, (Nov. 1996), 119(6) 1269-75.
Hcaplus Abstract, Accession No. 1997:208265, Kaneko, Furi Rajikaru no Rinsho (1995), 9, 116-123.
Hcaplus Abstract, Accession No. 1996:628073, Kitajima et al., Japanese Patent No. 08208464 (1996).
Hcaplus Abstract, Accession No. 1988:509240, Kawamur et al., Ganryu Aminosan (1987), 10(1), 99-107.
Database CAPLUS on STN, American Chemical Society (ACS), Columbus, OH, USA), DN. 122:305890 & Salabert-Salvador, M.T. et al., QSAR relations from molecular connectivity of various physicochemical and pharmacological properties of a group of hypolipemic drugs, Ars Pharm., 1992, 33 (1-4, vol. 2), pp. 1086 to 1090.
Sulfur Amino Acids, vol. 7, No. 1, 201-205 (1984).
Geriat., Med., vol. 19, No. 3, 415-422 (1981).
Grundy, Medical Intelligence, Drug Therapy, “HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia”,New England Journal of Medicine, vol. 319, No. 1, Jul. 7, 1988, pp 24-33.
Modern Physician, vol. 18, No. 1, 53-56 and 69-71 (1998).
Lin, Jin-Xiu, et al., “The Effect of Pravachol, Inositoli, Nicotinatis and Combining Treatment on Blood Lipid in Patients with Hyperlipidemia,”Chin. J. Arterioscler., 1997, pp. 227-230, 5(3); (and English Language Translation).

Affiliated with

Also associated with

Rating

Lipid peroxide-lowering compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lipid peroxide-lowering compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipid peroxide-lowering compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3666786